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Out of the night that covers me,  
      Black as the pit from pole to pole,  
I thank whatever gods may be  
      For my unconquerable soul.  
 
In the fell clutch of circumstance  
      I have not winced nor cried aloud.  
Under the bludgeonings of chance  
      My head is bloody, but unbowed.  
 
Beyond this place of wrath and tears  
      Looms but the Horror of the shade,  
And yet the menace of the years  
      Finds and shall find me unafraid.  
 
It matters not how strait the gate,  
      How charged with punishments the scroll,  
I am the master of my fate,  
      I am the captain of my soul. 




O metilfenidato (Ritalina®) é um fármaco estimulante utilizado no tratamento do 
transtorno de déficit de atenção e hiperatividade. Recentemente, houve um 
incremento consumo de metilfenidato entre adultos jovens, principalmente 
estudantes de universidade, que usam o fármaco com o intuito de aprimorar as suas 
funções cognitivas e melhorar o seu desempenho académico. Contudo, ainda não é 
claro se o uso do metilfenidato traz benefícios para usuários saudáveis (sem o 
diagnóstico de transtorno de déficit de atenção). Além disso, não há claridade sobre 
os efeitos do metilfenidato na motivação e como eles interagem com os efeitos em 
cognição para influenciar no desempenho. O objetivo desse estudo é avaliar os 
efeitos da administração aguda ou crónica de metilfenidato (0.3, 1 ou 3 mg/kg i.p.) 
na memoria e na motivação em ratos. Para isso ratos foram treinados na tarefa de 
labirinto radial de oito braços, com três braços reforçados com 1, 3 ou 6 pellets de 
sacarose, que se mantiveram estáveis ao longo do experimento. Nós avaliamos o 
desempenho no labirinto quantificando o número de entradas nos braços não 
reforçados e o número de reentradas nos braços reforçados. A administração aguda 
de metilfenidato foi avaliada no último dia do treino e não mostrou nenhum efeito no 
desempenho, sugerindo que o metilfenidato não tem nenhum efeito sobre memorias 
já estabelecidas. A administração crónica de 3mg/kg metilfenidato incrementou o 
número de reentradas aos braços com 3 e 6 pellets a partir do día 11 do treino. Este 
aumento nas reentradas não foi observado para o braço com 1 pellet, e nem em 
animais treinados com a mesma quantidade de pellets em todos os braços. Nós 
sugerimos que este aumento nas reentradas não reflete uma piora na memoria, mas 
pode refletir um aumento na motivação a procurar recompensas altas. Nós 
concluímos que o metilfenidato não possui efeitos na memoria, porem, pode piorar o 





Methylphenidate (Ritalin ®) is a stimulant used in the treatment of attentional deficit 
and hyperactivity disorder. The use of methylphenidate by healthy young adults has 
increased recently, mainly among college students who use it with the intention to 
improve their cognitive functions and have a better academic performance. However, 
it is not clear if the use of methylphenidate has benefits for healthy subjects (people 
without the diagnose for attention deficit and hyperactivity disorder). Furthermore, it is 
not clear what are the effects of methylphenidate on motivation and how they interact 
with the effects in cognition, influencing performance. This study aims to evaluate the 
effects of acute or chronic methylphenidate administration (0.3, 1 or 3 mg/kg i.p.) in 
memory and motivation, in rodents. To this end, rats were trained in the radial arm 
maze task, with three reinforced arms that remained stable across the experiment, 
and that contained 1, 3 or 6 sucrose pellets. We evaluated performance quantifying 
the entries in the non-reinforced arms and the re-entries in the reinforced arms. 
Acute administration of methylphenidate was evaluated on the last day of training, 
and it did not show any effect on performance, suggesting that methylphenidate does 
not have any effect on memory that is well established. From the 11th day of training, 
chronic administration of 3mg/kg of methylphenidate increased the number of re-
entries in the arms that contained 3 or 6 sucrose pellets.  This increase in the re-
entries did not occur for the arm baited with 1 pellet, nor for animals trained with the 
same amount of reward in the three arms. We propose that this increase in re-entries 
does not reflect impairment in working memory, but it may reflect an increase in 
motivation to search for high rewards. We conclude that methylphenidate does not 
have effects on memory, but it can affect performance indirectly, by effects in other 





ADHD – Attention Deficit and Hyperactivity Disorder 
ANVISA – National Health Surveillance Agency (in Portuguese Agencia Nacional de 
Vigilancia Sanitária) 
DAT – Dopamine Transporter 
SNc – Substantia Nigra pars compacta 
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This thesis presents original results divided in seven sections: introduction, 
methods, results, discussion, conclusion and references. At the end of the document 






Methylphenidate is a stimulant that was synthesised for the first time in 1944 in 
Switzerland, and now is the active compound of Ritalin ® and Concerta ®. It is used 
primarily to treat attention deficit and hyperactivity disorder (ADHD), and it can be 
used to treat narcolepsy and depression as well (Challman e Lipsky, 2000).  
Although methylphenidate has therapeutic uses, it also has some problematic 
side effects. In the Controlled Substances Act, a federal U.S. drug policy, 
methylphenidate is classified as a schedule II drug, which means methylphenidate is 
considered a substance with a high potential for abuse, and yet it has therapeutic 
uses. In Brazil, the National Health Surveillance Agency (ANVISA) also recognises 
methylphenidate as a substance with potential for abuse and classifies it under the 
black strip category, which is reserved for the highest controlled drugs.  
The abuse potential of methylphenidate arises from the fact that it blocks 
dopamine transporters and increases dopaminergic transmission (Ritz et al. 1987; 
Ritz and Kuhar 1988; Volkow 1998). This mechanism of action is similar to cocaine 
and amphetamine, and virtually, all drugs with the potential of abuse increase 
dopaminergic transmission either directly or indirectly (Volkow e Morales, 2015). 
1.1. EFFECTS OF METHYLPHENIDATE ON DOPAMINERGIC TRANSMISSION. 
Dopamine is a catecholamine neurotransmitter (Carlsson et al., 1957; 
Carlsson e Waldeck, 1958; Carlsson, 1959) produced in the mammalian brain in ten 
different regions identified as A8-A17 (Figure 1) by Dahlstrom and Fuxe (1964). The 
most studied nuclei are A9 and A10, located in the midbrain, also known as 
substantia nigra pars compacta (SNc) and ventral tegmental area (VTA). These two 
nuclei innervate structures in the forebrain, forming three different pathways: one that 
reaches the dorsal and ventral striatum, one that reaches limbic structures (for 
example the amygdala and the septum), and one that reaches the cortex (Lindvall et 
al., 1974; Lindvall et al., 1977; Fallon, Koziell, et al., 1978; Fallon e Moore, 1978a; b; 
Fallon, Riley, et al., 1978). 
These dopaminergic pathways are of particular interest because of their 
involvement in motivation and learning (Bromberg-Martin et al., 2010; Da Cunha et 
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al., 2012). Regarding motivation, evidence suggests that dopamine is involved in 
reward approach or reward-seeking behaviours (Salamone e Correa, 2012). An 
example of this notion is an experiment that shows that animals with chronically 
elevated dopamine show higher motivation to work for food reward (measured as the 
breakpoint in a progressive ratio) (Cagniard et al., 2006). This example illustrates that 
higher dopamine levels correlate with states of higher motivation to search for 
rewards. Likewise, dopamine release decreases if the animal has a low motivation 
for food reward (for example if the animal is satiated), and if the cost of the reward 
increases (Ostlund et al., 2011). This example illustrates that lower dopamine levels 
correlate with states of lower motivation to search for a reward. Considering this, 
authors have proposed that dopamine signals incentive salience or ‘wanting’ for a 
reward (Robinson et al., 2005; Berridge, 2007). 
 
Figure 1. Sagittal view of dopaminergic nuclei in the rat brain. Source: Bjorklund and 
Dunnet (2007). 
In addition, extensive evidence demonstrates that dopamine conveys a signal 
for reward prediction error: unexpected rewards trigger a rapid increase in the firing 
of dopaminergic neurons and dopamine release (Schultz, 1997; Schultz et al., 1997; 
Bromberg-Martin e Hikosaka, 2009; Hart et al., 2014). A similar rapid increase 
happens with cues that predict the apparition of reward (Bromberg-Martin e 
Hikosaka, 2009) and with rewards that are higher than expected (Bayer e Glimcher, 
2005). On the other hand, if an expected reward fails to appear there is a pause in 
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dopaminergic neurons firing (Schultz et al., 1997). These reward prediction error 
signals are proposed to mediate associative learning (Steinberg et al., 2013).   
The Dopamine transporter (DAT) is one of the mechanisms that regulate 
extracellular dopamine levels. It takes dopamine from the synaptic cleft and brings it 
back to the presynaptic cell. Acute administration of therapeutic doses of 
methylphenidate blocks between 50% - 75% of DAT (Figure 2) in the human brain 
(Volkow et al., 1998), which increases extracellular levels of dopamine in the striatum 
(Volkow et al., 2001). Chronic administration of methylphenidate produces some 
adaptations in the system: it reversibly increases the expression of DAT in the 
striatum (Robison et al., 2017); and it also increases the rates of dopamine uptake 
and increased dopamine release (Calipari et al., 2014).  
At the behavioural level, studies show that chronic methylphenidate alters the 
circadian rhythms of male and female rats (Algahim et al., 2009; Lee et al., 2011) and 
increases self-administration of cocaine, nicotine and amphetamine in rats (Thanos 
et al., 2007; Wooters et al., 2008; Crawford et al., 2011; Calipari et al., 2013). Both 
effects are likely related to alterations in dopamine release described earlier. Thus, 
chronic methylphenidate induces a sensitisation dopaminergic transmission reflected 
at the molecular, physiological and behavioural levels.  
 
Figure 2. Mechanism of action of methylphenidate. This figure was prepared by MSc. 




1.2. OFF-LABEL METHYLPHENIDATE USE IN BRAZIL 
Methylphenidate is available in Brazil since 1998, and its consumption shows 
a trend toward increase. Data from ANVISA indicate that consumption went from 
156.62 kg in 2009 to 413.38 kg in 2011 (Anvisa, 2012). Off-label use may partially 
explain this phenomenon (off-label refers to the use of prescription drugs by healthy 
people who do not have a medical prescription).  
Off-label methylphenidate use among young adults is a marked phenomenon 
in countries such as the United States, where it went from 8% in 2003 to 12% in 2013 
(Mccabe et al., 2014 & Boyd, 2014). In Brazil, this phenomenon seems to have 
momentum as well. Multiple studies show that the prevalence of off-label use of 
methylphenidate among college students goes from 5.30% to 60% (see Table 1). 
However, to the best of our knowledge, no studies have assessed this phenomenon 
in the general population of young adults or the whole country. Thus, these 
percentages are likely lower if we consider the general population, as college 
students are at higher risk to engage in off-label methylphenidate use (Herman-Stahl 
et al., 2007). In addition, we cannot estimate how this trend of off-label 
methylphenidate use has changed over time in Brazil. 
The main reason reported by students to engage in off-label methylphenidate 
use is to improve their academic performance (Lage et al., 2015). However, only two 
studies assessed if methylphenidate consumption correlates with better performance. 
Both studies were carried out in the United States, and neither could find a positive 
correlation between off-label methylphenidate use and academic performance (Arria 
e Wish, 2006; Munro et al., 2017). We could not find studies addressing the relation 
of academic performance and off-label methylphenidate use in Brazil. Thus, the 
relationship between off-label use of methylphenidate and academic performance is 






Table1. Studies addressing the prevalence of off-label use of methylphenidate in 
college students in Brazil 
 
1.3. EFFECTS OF METHYLPHENIDATE ON COGNITION 
Most of the studies that evaluate the effects of methylphenidate focus on 
laboratory tests that measure a specific cognitive domain. Here we report studies in 
two domains that are of particular interest for this study: episodic and working 
memory. 
Author, 
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1.3.1. EFFECTS OF METHYLPHENIDATE ON EPISODIC MEMORY 
Episodic memory is the ability to acquire, consolidate, store and retrieve 
information related to episodes (Tulving, 2002; Moscovitch et al., 2016). It contains 
specific information about the time and place of the acquisition and can be 
understood as the mental replay of the situation. Typical laboratory tests that 
measure episodic memory are testing memory for narratives, and word recognition 
and recall such as the Rey’s Auditory Verbal Learning Test (Moradi et al., 2017). 
Methylphenidate seems to enhance episodic memory. A meta-analysis that 
assessed 42 single administration studies found a positive effect of methylphenidate 
(Repantis et al., 2010). Likewise, a review concluded that single administration 
methylphenidate and amphetamine benefit memory and the longer the delay 
between the training and the test, the stronger the benefit (Smith e Farah, 2011). 
More recently, another meta-analysis found a small but significant positive effect in 
short- and long- term episodic memory, although the authors suggest a possibility of 
publication bias  (Ilieva et al., 2015) 
1.3.2. EFFECTS OF METHYLPHENIDATE ON WORKING MEMORY 
Working memory is the capability to temporarily store and manipulate 
information to use in the current task (Baddeley, 2003; 2010; 2012). Several tests 
measure working memory; the oldest and most common is the Sternberg test 
(Sternberg, 1966). In this task, participants are exposed to a list called memory set. 
After a few seconds, the participant is exposed to an item and needs to identify if the 
item belongs to the memory set or not. To resolve this task, the participant needs to 
maintain the information of the set in the working memory.  
Methylphenidate has controversial effects in working memory. A review found 
mixed results, with some studies that found improvement and some did not find 
effects (Smith e Farah, 2011). The authors argue that this may be due to individual 
differences: for example, amphetamine administration does not have any effect on 
people with an allele that decreases the enzyme that metabolizes dopamine and 
norepinephrine, while it has a beneficial effect in people with most active form of the 
enzyme (Mattay et al., 2003). Likewise, a most recent review found an improvement 
in working memory with doses between 10 and 20 mg of methylphenidate, but not 
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with doses above or below this range (Linssen et al., 2014). Thus, methylphenidate 
may improve working memory depending on the dose and individual characteristics 
of the person taking it. 
 
   
Figure 3. Example of temporal sequence of the Sternberg Task. Source: Jansma, 
(2013) 
1.3.3. USE OF RODENTS IN COGNITIVE AND BEHAVIORAL STUDIES 
Studies in laboratory settings in humans are useful assessing the effects of 
drugs on cognition and behavior, but they have limitations such as a high 
heterogeneity among participants, and lack of control of several variables that may 
interfere in the results, and a difficulty to make chronic treatments. These limitations 
can be surpassed with the use of animal models in the behavioral and 
pharmacological studies. In particular, mice and rats are suitable subjects, commonly 
used in the study of behavior and cognition; and one of the cognitive functions most 
studied in rodents is spatial memory.  
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Spatial memory is the ability to acquire, consolidate, store and retrieve 
information regarding locations and routes; and to use this information to navigate 
successfully in the environment (Vorhees e Williams, 2014). It is widely studied in 
rodents, because is one of high cognitive functions that they display, and because it 
shares neural mechanisms with episodic memory in humans. There are several 
behavioural tests used to assess spatial memory in rodents. In this study, we used 
the eight-arm radial arm maze. This test was developed by Olton in 1976 and 
measures spatial memory (Olton e Samuelson, 1976). The radial arm maze consists 
of a central octagon from which eight runaways or arms irradiate (Figure 4), at the 
distal end of each arm there is a receptacle where the animal can find a food reward. 
The maze is surrounded by distal visual cues that remain stable through the 
experiment, and that the animal can use to navigate. Other common test used to 
evaluate spatial memory is the water maze, which is a circular pool with a hidden 
platform; animals must learn the location of the platform based on visual cues that 
surround the maze (Vorhees e Williams, 2014).  
 
Figure 4. Schematic representation of an eight-arm radial arm maze.  
1.3.4. EFFECTS OF METHYLPHENIDATE ON RODENTS SPATIAL MEMORY 
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Few studies have assessed the effects of methylphenidate on spatial memory 
and have yielded controversial results. Veetil (2011) found an improvement in the 
radial arm maze with 3mg/kg of methylphenidate administered i.p. every day before 
training, for four days. Sontag (2011) did not have any effect of 2.5 mg/kg of 
methylphenidate on working and reference memory, administered for five days, every 
day before behavioural testing, to animals that were well trained. In the same study, 
Sontag found that 10 mg/kg impaired memory. Haleem (2015) found that 
methylphenidate improved memory consolidation at doses from 0.25-1 mg/kg 
administered every day after water maze training during one week; after a gap of a 
week without training, the animals that received the methylphenidate remembered 
the task better than the controls. Sloan (2016) found no effects of 0.75 and 1.5 mg/kg 
of methylphenidate in the performance of the radial arm maze. The animals were well 
trained on the task, and the drug was administered 15 minutes before testing. Hence, 
it seems that methylphenidate will yield different effects on memory depending on the 
dose, the moment of the administration and whether the animals are well trained or 
not. 
One issue that has not been explored is how the effects of methylphenidate on 
motivation influence performance in cognitive tasks; to answer this question is the 
aim of this study. To this aim, we treated separate groups of rats with four different 
doses of methylphenidate (0, 0.3, 1 or 3 mg/kg) and trained them in an eight-arm 
radial arm maze that had three reinforced arms that remained stable across the 
training. Each reinforced arm had a different amount of reward, one arm contained 1 
sucrose pellet, other arm contained 3, and the last arm contained 6 sucrose pellets. 
We trained a separate group of animals in the same task, but with the same amount 
of reward in the three arms, to isolate the effects on memory from the effects on 
motivation.  
We found that animals that received chronic treatment with 3 mg/kg of 
methylphenidate displayed a higher number of re-entries in the high rewarded arms 
(the ones that contained 3 or 6 sucrose pellets). This increase did not occur in 
animals trained with the same amount of reward in all arms; hence, we propose that 
this effect is the result of increased motivation to search for high rewards, rather than 
impairment in working memory. In addition, we assessed both the acute and chronic 
effects of methylphenidate on anxiety and locomotion, to rule out that the observed 
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effects were mediated by emotional or motor processes. This assessment did not 
reveal any effect of methylphenidate in anxiety or locomotion. We conclude that the 
effects of methylphenidate are complex, and presented in several domains such as 




2. AIM  
To investigate what are the effects of methylphenidate on memory and 
motivation, and how each influences performance in cognitive tasks. 
2.1. OBJECTIVES 
To evaluate the effects of acute methylphenidate (0, 0.3, 1 and 3 mg/kg; i.p.) 
in the scores for working and reference spatial memory in the radial arm maze, in 
well-trained rats. 
To evaluate the effects of chronic methylphenidate (0, 0.3, 1 and 3 mg/kg; i.p.) 
in the scores for working and reference spatial memory in the radial arm maze, in 
rats.  
To evaluate the effects of chronic and acute methylphenidate in the scores for 
anxiety in the elevated plus maze, in rats. 
To evaluate the effects of chronic and acute methylphenidate in the scores for 
locomotor behaviour and anxiety in the open field, in rats. 






Two hundred and eight adult male Wistar rats from our breeding stock were 
used in these experiments. The animals were maintained in standard conditions, in a 
room with controlled temperature (22±2ºC), on a 12h/12h light/dark cycle, with the 
light period beginning at 7:00 am. The rats used in the radial arm maze experiments 
were kept under food restriction to maintain  90% of their free-feeding weight (300–
350 g). The rats used in the open field and elevated plus-maze experiments had food 
ad libitum.  Water was available ad libitum for all rats. The food, the water intake, and 
the weight of the animals were monitored daily. All experimental procedures were 
approved by the Federal University of Parana Ethical Committee for Animal Care 
(protocol 932) and complied with Brazilian (11.794/8 October 2008) and International 
Laws (EC Council Directive, 24 November 1986; 86/609/EEC). Efforts were made to 
minimise the rats' discomfort. 
3.2. DRUGS 
Methylphenidate (Ritalin, Novartis Pharma) was dissolved in saline (0.9% 
NaCl). The doses of methylphenidate (0.3 mg/kg, 1.0 mg/kg and 3.0 mg/kg) were 
chosen based on the allometric calculation  (Nevill, 1994) for therapeutic doses for 
humans corresponding to 10 – 60 mg for adults of 70 kg (0.14-0.85 mg/kg). Each rat 
received an intraperitoneal (i.p.) administration of one of the three doses, or saline, 
30 min before the behavioural tests. In the acute experiment the drug was injected 
only on the testing day; in the chronic experiments, the drug was injected once a day 
during the whole duration of the experiments (20 days). 
3.3. BEHAVIOURAL PROCEDURES 
The radial maze task. The radial maze consisted of 8 62x14cm arms with 
2cm barriers, and a central octagon arena (36 cm diameter) elevated 66 cm above 
the floor, all painted in black. A circular receptacle (1 cm diameter, 0.1 cm depth) was 
located at the distal end of each arm. The maze remained in the same location in all 
sessions. The walls of the room were covered with a white curtain. Several coloured 
geometric figures were attached in the wall to serve as distal cues. The behaviour of 
the rats in the maze was videotaped by an overhead camera (Stingray) operating at 
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60 fps and digitised by the CinePlex® behavioural research system (Plexon Inc., 
Texas). Before training, rats underwent behavioural shaping. On Day 1 they were 
allowed to explore the whole maze for 5 minutes. On Day 2, 5 mg sucrose pellets 
were distributed along each arm of the maze (total of 40 pellets), and the rats were 
allowed to explore the maze for 10 minutes. This procedure was repeated daily until 
each rat had consumed at least 36 pellets in a session. In the next two days the 
procedure was repeated with three pellets per arm and, and in the next day the 
exploration time was reduced to 5 min and each arm was baited with only one pellet 
located in the receptacle. Only the animals that did not consume all pellets were 
further used and underwent daily training sessions with four trials per session. On 
each trial, three arms were baited, and this arms remained stable across the 
experiment. The baited arms were counterbalanced among rats. For each rat, the 
baited arms were the same, and there was at least one non-baited arm between two 
baited arms. In each trial the rat was released in one of the non-baited arms, 
alternated among trials in a counterbalanced manner, and allowed to explore the 
maze until all pellets were consumed or until 5 minutes had elapsed. The rats 
remained in a holding cage in the 1-min interval among trials. 
The elevated plus maze test. Independent groups of rats were evaluated in 
this test as a control to evaluate whether the effect of methylphenidate on the radial 
maze was a consequence of the effect of this drug on anxiety. The elevated plus-
maze consisted of two open arms, (50x10cm) and two closed arms (50x10cm and 50 
cm height walls) elevated 50 cm above the floor. The closed arms were 
perpendicular to the open arms, and the all arms give access to a 10x10cm maze. 
The rats were allowed to explore the maze freely for 5 minutes. Rats were 
videotaped by an overhead camera operating at 60 fps, and their trajectories of the 
animals were digitalised by the ANY-maze® Behavioural tracking system (Stoelting 
Co, IL). The number of entries and time spent in the open and closed arms were 
scored. Anxiety index was calculated as 1 – [(time in open arms/total time[300 
seconds])+(entries in open arms/total entries)]/2; this index had values that vary from 
0 to 1;  higher values indicate higher anxiety (Huynh, Krigbaum, Hanna, & Conrad). 
The open field test. The open field apparatus consisted of a circular arena of 
100 cm diameter surrounded by a 45 cm wall. The floor and the walls were painted in 
white. Rats were videotaped from above for 5 minutes. The same video-camera and 
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tracking system described above were used. The travelled distance was used as a 
score of locomotor behaviour. The time spent in the periphery vs the time in the 
central zone (20 cm far from the walls) were used as scores of anxiety (Prut & 
Belzung, 2003). 
3.4. EXPERIMENTAL SCHEDULES 
Experiment 1. Acute effects of methylphenidate on the radial maze 
scores. During the training and test sessions, three arms of the radial maze were 
baited with 1, 3, or 6 sucrose pellets. All the animals were trained for 30 days or until 
they entered three times or less in non-baited arms during the entire session (75% of 
correct choices) for three consecutive days. In the last day, thirty minutes before the 
last session, the rats received vehicle or 0.3, 1.0, or 3 mg/kg methylphenidate (i.p.). 
Experiment 2. Chronic effects of methylphenidate on the radial maze 
scores. The number of pellets in the baited arms and drug treatment was the same 
as in Experiment 1. However, i.p. injections were given 30 min before each training 
for 20 days. The trajectory of the animals within the mazes was videotaped by an 
overhead camera operating at 60 fps and digitalised by the ANY-maze® Behavioural 
tracking system (Stoelting Co, IL). From the video recordings of the test, it was 
extracted: the number of visits and revisits to the baited and non-baited arms, and 
the time spent in the central part of the maze, and in the distal part of each baited 
arm (20x14cm around the reward receptacle). 
Experiment 3. Chronic effects of methylphenidate on the radial maze 
scores. Three arms were baited with one sucrose pellet each. Rats were given 20 
daily sessions of training.  Thirty minutes before each training session rats received 
saline or 3 mg/Kg of methylphenidate i.p. 
Experiment 4. Acute and chronic effects of methylphenidate on the open 
field test. Independent groups of rats received the same drug treatment of 
Experiment 2 and were tested in the open field on days 1 and 20. Drugs were given 
30 min before each test. 
Experiment 5. Acute and chronic effects of methylphenidate on the EPM 
test. Another independent group of rats received the same drug treatment of 
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Experiment 2 and were tested in the elevated plus-maze on days 1 and 20. Drugs 
were given 30 min before each test. 
Experiment 6. Acute effects of methylphenidate on sucrose intake. Food-
deprived rats were habituated to sucrose pellets, a week before the behavioural 
testing. On the test day, rats received i.p. injections of vehicle or 3 mg/kg of 
methylphenidate. Thirty minutes after administration they were put in a cage identical 
to their home cage to have access to 20 g of 5 mg sucrose pellets. The animals were 
allowed to stay in this cage for 15 minutes, and then they returned to the home cage. 
The amount of food eaten during these 15 minutes was measured. This procedure 
repeated for two days. 
3.5. STATISTICAL ANALYSIS 
Experiment 1. Four parameters were analyzed from the data collected in 
experiment 1: a) the entries in non-reinforced arms from the first to the penultimate 
day (day 1 – day 34), to determine if all the groups learned the task and if all of them 
had a similar performance; b) the entries in non-reinforced arms on the last day, to 
evaluate the effects of acute methylphenidate on the expression of reference 
memory; c) the reentries in the reinforced arm, to evaluate the effects of acute 
methylphenidate on working memory; and d) the reentries on each separate 
reinforced arm, to assess the effects of methylphenidate on motivation.   
The first parameter, entries in the non-reinforced arms from the first ot the 
penultimate day, was analyzed using a two-way repeated measures ANOVA, with 
time and treatment as the two factors. The second and the third parameters, the 
entries in the non-reinforced arms and the reentries in the reinforced arms, were 
analyzed with a one-way ANOVA, with treatment as a factor. Finally, the fourth 
parameter, the reentries on each separate arm, was analyzed with a two-way 
ANOVA, with treatment and reward amount as factors. 
Experiment 2. From the data collected in experiment 2 were analyzed the 
entries in the non-reinforced arms, the reentries to all reinforced arms and to each 
arm separate, the time spent on each region of the maze (on each reward zone and 
on the center), the total entries, and the distance travelled. All of them were analyzed 
for the entire experiment (20 days), and all of them were analyzed with two-way 
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repeated measures ANOVA, with the time and treatment as factors; except the 
reentries on each separate reinforced arm, which was analyzed with a three-way 
repeated measures ANOVA, with time, treatment and reward amount as factors. In 
addition, the time spent on the center of the maze was correlated with the entries in 
the non-reinforced arms and with the reentries to all reinforced arms. These 
correlations were made for each treatment separately.  
Experiment 3. For the experiment were also analyzed the entries in the non-
reinforced arms and the reentries in all reinforced arms, during the entire experiment. 
Both parameters were analyzed with a two-way repeated measures ANOVA, using 
time and treatment as factors.  
Experiments 4 and 5. Three parameters were analyzed in experiment 4: the 
time in the closed arms, the percentage of entries in the open arms, and the index 
anxiety as explained above. Regarding experiment 5, the parameters analyzed were 
the distance travelled and the percentage of time spent in the center of the maze. 
Both analysis were performed for day 1 and day 20 of the treatment, to assess both 
the acute and chronic effects of methylphenidate. In all cases the data was analyzed 
using one-way ANOVA, with treatment as factor. 
Experiment 6.  One parameter was assessed in experiment 6, the amount of 
sucrose pellets eaten. This parameter was measured both days that lasted the 
experiment and the data was analyzed with a two-way repeated measures ANOVA, 




Experiments 1, 2, and 3, assessed the effects of methylphenidate on a radial 
arm maze paradigm. The aims were to assess: a) reference memory by comparing 
the number of entries to non-rewarded arms among groups, and b) working memory 
by comparing the number of re-entries to rewarded arms. Experiment 2 also 
assessed the effects of methylphenidate in motivation, comparing the preference of 
the animal for different amounts of reward. 
Experiments 4, 5 and 6 assessed the effects of methylphenidate on the open 
field and the elevated plus maze, and on sucrose consumption. These experiments 
were performed to rule out any effect on anxiety, locomotion and appetite that could 
blunt the effects on memory. 
4.1. EFFECTS OF ACUTE ADMINISTRATION OF METHYLPHENIDATE ON 
RADIAL ARM MAZE PERFORMANCE. 
Experiment 1. In this experiment assessed the effects of acute 
methylphenidate on memory. As expected, all groups decreased the entries to the 
non-reinforced arm in a significant and progressive manner, and their performance 
showed no significant differences (Figure 5A; Table 3). Thirty minutes before the last 
session, rats received an injection of vehicle or one of the three doses of 
methylphenidate. The number of entries to non-reinforced arms in the last day did not 
differ among groups (Figure 5B; Table 2). The number of re-entries in all reinforced 
arms in the last day also did not differ among groups (Figure 5C; Table 2); however, 
when we separated the re-entries per arm, we found that animals from the vehicle 
group entered more in the high-rewarded arm than in the low reward arm (Figure 5D; 
Table 3). Thus, acute methylphenidate did not affect working memory or the 




Figure 5. The acute treatment with methylphenidate did not altered the performance 
in the radial arm maze. Three out of the eight arms were baited with 1, 3, or 6 pellets. 
Bars express mean ± SEM. A: Entries in non-reinforced arms in 5-days bins.  B: 
Entries in non-rewarded arms the next day after the last day in A . bin. C: Reentries 
in all rewarded arms. D: Reentries in each separated rewarded arm. MPH 0.3, 1 and 
3: methylphenidate 0.3, 1 and 3 mg/kg, respectively. Each group N = 10.  Data are 
expressed as mean ± SEM. b: p < 0.05 compared to the 1st bin of the same group, 
Tukey post hoc test after ANOVA. 
 
Table 2. Effects of methylphenidate on reference and working memory, and on 
anxiety and locomotor measures analyzed with one-way ANOVA statistics  
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MPH 0.3, 1 or 3 methylphenidate 0.3, 1, 3 mg/kg. For open field measures: Vehicle 
N=10, MPH 0.3 N=10, MPH 1 N=10, MPH 3 N=11. For elevated plus maze 
measures: Vehicle N=11, MPH 0.3 N=11, MPH 1 N=12, MPH 3 N=12. 
 
Table 3. Effects of methylphenidate on reference and working memory, and sucrose 
intake analyzed with two-way ANOVA statistics  
F p
Entries in non reinforced arms last day (Exp. 1) 1.46 0.24
Reentries in all reinforced arm last day (Exp. 1) 0.44 0.72
Distance travelled in the OF (acute) 0.09 (3, 37) 0.96
Distance travelled in the OF (chronic) 1.54  (3, 37) 0.21
% of time in the center of the OF (acute) 0.92 (3, 37) 0.43
% of time in the center of the OF (chronic) 0.36 (3, 37) 0.78
% of time in the closed arms of the EPM (acute) 3.71 (3, 42) 0.01
% of time in the closed arms of the EPM (chronic) 1.22 (3, 42) 0.31
% of entries in the closed arms of the EPM (acute)  0.03 (3, 42) 0.98
% of entries in the closed arms of the EPM (chronic) 0,43 (3, 42) 0.72
Anxiety index (acute) 1.27 (3, 42) 0.29
Anxiety index (chronic) 1.82 (3, 42) 0.15
Total number of entries in arms EPM (acute) 0.07 (3, 42) 0.97





MPH 0.3, 1 or 3 methylphenidate 0.3, 1, 3 mg/kg. 
 
4.2. EFFECTS OF CHRONIC ADMINISTRATION OF METHYLPHENIDATE ON 
RADIAL ARM MAZE PERFORMANCE 
Experiment 2. In this experiment, three arms of the radial arm maze were 
rewarded, and each arm contained a different amount of reward; this arrangement 
allowed us to evaluate reference and spatial memory, and at the same time to 
evaluate motivation by comparing the number of visits the animals did to each 
rewarded arm. 
All groups decreased the entries to the non-reinforced arm in a significant and 
progressive manner (Figure 6A). In the first five days, rats treated with 1 and 3 mg/kg 
of methylphenidate entered less in the non-reinforced arms than rats treated with 
F p F p F p
Reentries in each arm in the last day  (Exp. 
1) Factor 1=Treatment, Factor 2=Reward 5.31 (2,108) <0.01 0.59(3,108) 0.61 1.01 (6,108) 0.42
Entries in non reinforced arms (Exp. 2) 
Factor 1=Treatment, Factor 2=Time 0.59 (3,36) 0.63 96.14(3,108) <0.0002 3.53 (9,108) <0.002
Reentries in reinforced arms (Exp. 2)Factor 
1=Treatment, Factor 2=Time 3.19 (3,36) <0.05 17.22 (3,108) <0.0001 4.48 (9,108) <0.0001
Time spent in the central compartment (Exp. 
2) Factor 1=Treatment, Factor 2=Time 8.10 (3,36) <0.05 21.30 (3,108) <0.0001 1.90 (9,108) 0.059
Distance travelled in the RAM (Exp. 
2)Factor 1=Treatment, Factor 2=Time 3.28 (3, 36) 0.04 13.36 (3, 108)<0.0002 6.51 (9, 108) <0.0002
Entries in non reinforced arms (Exp. 3) 
Factor 1=Treatment, Factor 2=Time 1.72 (1,19) 0.20 66.76 (3,57) <0.0001 3.08 (3,57) <0.05
Reentries in reinforced arms (Exp. 3) Factor 
1=Treatment, Factor 2=Time 0.19 (1,19) 0.65 15.61 (3,57) <0.0001 1.09 (3,57) 0.36
Sucrose intake test (Exp. 6)Factor 
1=Treatment, Factor 2=Time 26.99  (1, 18) <0.0001 29.25  (1, 18) <0.0001 7.75  (1, 18) 0.01
Factor 1 Factor 2 Interaction
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vehicle (Figure 6A; Table 3). Chronic methylphenidate did not have any further effect 
in reference spatial memory. 
 
 
Figure 6. Effects of the chronic treatment with methylphenidate on the rats 
performance of the radial arm maze. Three out of the eight arms were baited with 1, 
3, or 6 pellets. Bars express mean ± SEM. A: Entries in non-reinforced arms in 5-
days bins.  B: Reentries in all reinforced arms. C: Reentries in arm baited with 1 
sucrose pellet. D: Reentries in arms baited with 3 and 6 sucrose pellets. MPH 0.3, 1 
and 3: methylphenidate 0.3, 1 and 3 mg/kg, respectively. Vehicle N = 10, MPH 0.3 N 
= 10, MPH 1 N = 9, and MPH  3 N = 11 Data are expressed as mean ± SEM. b: p < 
0.05 compared to the 1st bin of the same group, Tukey post hoc test after ANOVA. 
 
Next, we evaluated the effects of the chronic administration of 
methylphenidate over working memory. Animals treated with vehicle decreased the 
re-entries in the reinforced arm in a significant a progressive manner; this decrease 
did not occur for animals treated with any dose of methylphenidate (Figure 6B; Table 
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3). In the first five days, animals treated with 1 and 3 mg/kg of methylphenidate had a 
lower number of re-entries in the reinforced arms than animals treated with vehicle. 
From day 11 to 20, animals treated with 3 mg/kg had a higher number of re-entries in 
the reinforced arms than animals treated with vehicle. 
To know if the increased re-entries to the reinforced arms correspond to both 
reinforced arms or just to the high-rewarded ones, we compared the number of re-
entries to the 6-pellets arms with 3-pellets arms and found no differences between 
them (Figure 7; Table 4). Hence, for further comparisons, we decided to merge the 
data from the 6 and 3 pellets arms by averaging the entries to each and consider it a 
single category. Here upon we will refer to the merged data of the 6 and 3 pellets 
arms as high-reward arm and as low-reward, the arm baited with 1 pellet. From day 
11 to 20, animals treated with 3 mg/kg of methylphenidate showed more re-entries in 
high-reward arms than in low-reward arms; none of the animals treated with the other 
doses of methylphenidate or with vehicle showed this difference (Figure 6C and 6D; 
Table 4). 
Table 4. Effects of methylphenidate on the reentries to arms with high vs low reward 
analyzed with three-way ANOVA statistics 
 
MPH 0.3, 1 or 3 methylphenidate 0.3, 1, 3 mg/kg. 
F(DFn,DFd) p
Treatment (Vehicle, MPH 0.3, MPH 1 or 
MPH 3)
1.84 (3,288) 0.314
Reward Amount (high/medium, low) 94.45 (1,288) <0.000
Interaction Treatment * Reward 3.46 (3,288) <0.02
Time 25.21 (3,288) <0.000
Interaction Time * Treatment 4.55 (9,288) <0.000
Interaction Time * Reward 5.73 (3,288) 0.001
Interaction Time * Treatment * Reward 2,36 (9,288) 0.014






Figure 7. Effects of chronic treatment with methylphenidate in reentries to each 
separate arm. No differences found between reentries in high and medium arm for 
any group. All data are expressed as mean ± SEM.  
The analyses above show a reduction in entries to the non-reinforced arms 
and the number of re-entries to the reinforced arms for animals treated with 1 and 3 
mg/kg. Since it happened for both parameters, we decided to investigate if this 
reduction was related to a decreased exploratory activity rather than an enhanced 
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memory. To answer this, we analysed the number of total entries, the total distance 
travelled, and the time the animals spent on each zone of the maze. Regarding the 
total number of entries, during the first five days, animals treated with 1 and 3 mg/kg 
of methylphenidate had a lower number of total entries compared with animals 
treated with vehicle (Figure 8). In addition, from days  11 to 15, animals treated with 3 
mg/kg had a higher number of total entries compared with animals treated with 
vehicle. Regarding the distance travelled, animals treated with any of the three doses 
of methylphenidate travelled a shorter distance during the first five days, compared 
with animals treated with vehicle; and animals treated with 3 mg/kg travelled a longer 
distance than animals treated with the vehicle from days 11 to 15 (Figure 9; Table 3). 
  
Figure 8. Effects of chronic treatment with methylphenidate in exploratory behaviour 
in the radial arm maze. Animals treated with 1 and 3 mg/kg of methylphenidate 
entered fewer times, considering all arms, during the 1st block, compared to animals 
treated with vehicle. Animals treated with 3 mg/kg entered more times in all of the 
arms in the 3rd block, compared to vehicle. All data are expressed as mean ± SEM. a: 
p < 0.05 compared to vehicle, Tukey post hoc test after two-way ANOVA. 
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Figure 9. Distance travelled in the radial arm maze in the experiment with different 
amount of reward on each arm. MPH 0.3, 1 and 3: methylphenidate 0.3, 1 and 3 
mg/kg, respectively. Data are expressed as mean ± SEM.  Bars represent mean ± 
SEM of the total distance travelled. a: p < 0.05 compared to the vehicle group, Tukey 
post hoc test after two-way ANOVA. 
Next, we evaluated the exploratory activity of the rats by analysing the time 
spent on each zone of the maze.  Animals treated with 0.3 and 1 mg/kg of 
methylphenidate spent less time in the high reward area (the distal end of the arm in 
the area near the reward receptacle) in the 3rd and 4th bins compared with the 1st bin; 
in addition, animals treated with 0.3 mg/kg of methylphenidate spent more time in the 
high reward arm compared with low reward (Figure 10). 
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Figure 10. Effects of chronic methylphenidate in the time the animals spent on each 
reward area. A: No differences were found between groups or across time in the time 
the animals spent in the low reward arm. B: No differences found between groups in 
the time the animals spent in the high reward arm. Animals treated with 0.3 and 1 
mg/kg of methylphenidate spent less time in the high reward arms during blocks 3 
and 4 than in block 1. Finally, animals treated with 0.3 mg/kg spent more time in the 
high reward arm than in the low reward, during block 1. All data are expressed as 
mean ± SEM. b: p < 0.05 compared to 1st block, Tukey post hoc test after two-way 
ANOVA. c: p < 0.05 compared to low arm, Tukey post hoc test after two-way ANOVA 
 
Likewise, the time the animals spent in the central compartment of the maze 
was also analysed (Figure 11). Rats treated with 1 and 3 mg/kg of methylphenidate 
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spent more time in the central compartment of the radial maze than those treated 
with the vehicle, during the 1st bin (Figure 11A; Table 2). Overall, rats treated with 
vehicle spent 11 ± 9 s (mean ± SD) in the central compartment. Thus, we separated 
the trials within each group according to their duration: more than 20 seconds spent 
in the central area or 20 seconds or less. A Chi-square test revealed that there was a 
significant increase in the number of trials on which animals spent more than 20 s in 
the central compartment in the groups treated with 1 and 3 mg/kg of methylphenidate 




Figure 11. Effect of methylphenidate in the time rats spent in the central 
compartment of the radial maze. The arms were baited with 1, 3 or 6 sucrose pellets. 
A: time spent in the central compartment of the maze, arms were baited with 6 pellets 
(high reward), 3 or 1 pellets (low reward). Data are expressed as mean ± SEM.  p < 
0.05 compared to the vehicle group, Tukey post hoc test after two-way ANOVA. B: 
black represents the percentage of trials in which the time spent more than 20 s in 
the central zone; white represents the percentage of trials in which the time spent in 
the central zone was equal or lower than 20 s. The mean ± SD time vehicle rats 
spent in the central area was 11 ± 9 s; a: p < 0.05 compared to the vehicle group, 
after Chi-square analysis. C-F: Representative heat maps of exploratory behaviour in 
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the radial arm maze. L, arms baited with low reward (1 pellet); H, arms baited with 
high reward (3 or 6 pellets). A warmer colour indicates a higher time spent in the 
area.  
In addition, we represented the exploratory activity of every animal during the 
whole experiment in colour maps. This representation is a qualitative assessment of 
the exploratory activity, which helped us visualise on which regions of the maze the 
animals spent more time. A warmer colour indicates a higher level of exploratory 
activity in a determined zone of the maze. Illustrative examples of animals treated 
with vehicle, 0.3, 1 and 3 mg/kg of methylphenidate are in figures 11C, D, E and F. In 
this examples we can confirm that the animals treated with methylphenidate spent 
more time in the central compartment of the maze than the animals treated with 
vehicle. Colour maps of the entire group of animals treated with vehicle, 0.3, 1 and 3 
mg/kg of methylphenidate are in appendixes A, B, C and D. 
Next, we investigated how the amount of time the animal spent in the central 
compartment was related to their performance on the task. For each group, we made 
a correlation between the time spent at the central compartment of the maze and the 
number of entries in the non-reinforced arms. We made two separate correlations, 
one considering the trials with 20 seconds or less on the central compartment of the 
maze, and another one considering the trials with more than 20 seconds con the 
central compartment of the maze. Using the Pearson test, we confirmed that there is 
a positive correlation between the time spent in the central compartment of the maze 
and the number of re-entries in reinforced arms; this is true for all the trials on which 
the animals spent 20 seconds or less in the central compartment of the maze. When 
the trials on which the animals spent more than 20 s are considered, this correlation 
disappears for animals treated with vehicle and 0.3 mg/kg of methylphenidate and is 
the opposite for animals treated with 1 and 3 mg/kg. The Pearson coefficients are 




Figure 12. Correlation between the time spent in the central compartment before 
entering a non-reinforced arm and the number of entries in the non-reinforced arms.  
A-E: Only data of the trials in which rats spent less than 20 s in the central 
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compartment were included. F-G: Only data of the trials in which rats spent more 
than 20 s in the central compartment were included. * P < 0.05 Pearson’s test. 
The same correlation between the time spent in the central platform and the 
re-entries in the reinforced arms was done for the entries in the non-reinforced arms. 
As in the previous analysis, this correlation was done for each treatment, and 
separating the trials on which the animals spent 20 seconds or less from the trials 
that the animals spent more than 20 seconds. Pearson correlation also found a 
positive correlation between the time the animals spent in the central platform and 
the number of entries in the non-reinforced arms for all the treatments considering 
the trials on which the animals spent 20 seconds or less. No correlation was found 
between the time the animals spent in the central platform and the number of entries 
in the non-reinforced arms when the animals spent more than 20 seconds. The 




Figure 13. Correlation between the time spent in the central compartment before 
reentering a reinforced arm and the number of reentries in the reinforced arms.  A-E: 
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Only data of the trials in which rats spent less than 20 s in the central compartment 
were included. F-G: Only data of the trials in which rats spent more than 20 s in the 
central compartment were included. * P < 0.05 Pearson’s test.  
Experiment 3. The increase in re-entries to rewarded arms had two possible 
explanations: a) it could be the result of an impairment in working memory or b) it 
could be the result of an increase in motivation to search for high rewards. To resolve 
this point we performed the experiment 3. This experiment was similar to experiment 
2, but the three reinforced arms had the same amount of reward. Rats of both groups 
decreased the entries into the non-reinforced arm in a significant and progressive 
manner(Figure 14A). In addition, during the first five days, rats treated with 3 mg/kg 
of methylphenidate entered fewer times in the non-reinforced arms than the rats 
treated with saline.  No further effects of methylphenidate were found. 
Regarding re-entries in all reinforced arms, both groups decreased the re-
entries in a progressive and significative manner. Rats treated with 3 mg/kg of 
methylphenidate did not have any difference from animals treated with vehicle 




Figure 14. Effects of the chronic treatment with methylphenidate on the rats 
performance of the radial arm maze. Three out of the eight arms were baited with 
1pellet, each. Bars express mean ± SEM. A: Entries in non-reinforced arms in 5-days 
bins.  B: Reentries in all reinforced arms. MPH 3: methylphenidate 3 mg/kg. Vehicle 
N = 11, MPH 3 N = 10.  Data are expressed as mean ± SEM. b: p < 0.05 compared 
to the 1st bin of the same group, Tukey post hoc test after ANOVA. 
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4.3. EFFECTS OF METHYLPHENIDATE IN THE ELEVATED PLUS MAZE AND 
THE OPEN FIELD 
Finally, we studied if methylphenidate, in the acute or chronic doses, had 
effects in locomotion or anxiety measures. For open field measures  methylphenidate 
did not have any effect on the locomotion measured as travelled distance or anxiety, 
using the percentage of time spent in the central compartment of the open field as an 
inverse measure of anxiety (Table 2 and 5).  The same was true for the chronic 
treatment with methylphenidate for both locomotion and anxiety (Table 2 and 5). 
In the elevated plus maze, animals treated with methylphenidate did not show 
any difference in the percentage of entries in the closed arms, nor in the anxiety 
index, compared with animals treated with vehicle (Table 2 and 5). However, a 
difference in the percentage of time spent in the open arms was revealed between 
the animals treated with 0.3 and 1 mg/kg (Table 2 and 5). Finally, chronic 
methylphenidate did not have any effect in any of the scores of the elevated plus 
maze. 
Table 5. Effects of methylphenidate in open field and elevated plus maze scores 
 
Data are shown as mean ± SEM. Bonferroni’s test after two-way ANOVA. MPH 0.3, 1 
or 3 methylphenidate 0.3, 1, 3 mg/kg. 
Vehicle MPH 0.3 MPH 1 MPH 3
Mean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM
Distance travelled in the OF (acute) 27,34  ± 1,76 27,1 ± 2,59 25,77 ± 2,29 26,62 ± 2,34
Distance travelled in the OF (chronic) 17,1  ± 2,98 18,37  ± 2,90 23,31 ± 3,80 25,75 ± 2,71
% of time in the center of the OF (acute) 5,10 ± 0,83 5,89 ± 1,06 6,78 ± 1,63 7,63 ± 0,93
% of time in the center of the OF (chronic) 7,32 ± 3,42 7,86 ± 3,01 7,46 ± 1,80 11,5 ± 4,46
% of time in the closed arms of the EPM (acute) 58,07 ± 3,29 59,92 ± 2,36 46,9 ± 2,92 53,79 ± 3,29
% of time in the closed arms of the EPM (chronic) 72,95 ± 6,86 66,21 ± 2,71 59,65 ± 5,87 58,52 ± 7,23
% of entries in the closed arms of the EPM (acute) 48.54 ± 2.27 47.9 ± 3.16 47.3 ± 2.62 48.28 ± 2.91
% of entries in the closed arms of the EPM (chronic) 57,13 ± 4,26 56,26 ± 4,24 46,9 ± 3,08 52,06 ± 4,95
Anxiety index (acute) 0,59  ± 0,02 0,60  ± 0,02 0,54  ± 0,02 0,58  ± 0,02
Anxiety index (chronic) 0,72 ± 0,03 0,69 ± 0,03 0,62 ± 0,03 0,62 ± 0,04
Total number of entries in arms EPM (acute) 29,73 ± 1,82 28,55 ± 1,32 28,83 ± 2,02 29,58 ± 2,72




4.4. EFFECTS OF METHYLPHENIDATE ON SUCROSE PELLETS INTAKE 
Methylphenidate reduced the consumption of sucrose pellets. Animals treated 
with 3 mg/kg of methylphenidate consumed less sucrose on both days compared 
with the vehicle group; in addition, animals in the vehicle group eat more sucrose in 
day 2 compared with day 1, while animals treated with 3 mg/kg of methylphenidate 
did not increase the amount of sucrose eaten (Figure 15; Table 3). 
 
Figure 15. Effect of methylphenidate on food intake. Animals were exposed to 20 
grams of sucrose pellets and allowed to eat for 15 minutes. MPH 3: methylphenidate 
3 mg/Kg. Both groups had a N = 10.  All data are expressed as mean ± SEM. a: p < 
0.05 compared to the vehicle group. b: p < 0.05 compared to the same group on Day 
1. Tukey post-hoc test after two-way ANOVA 
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This study aimed to evaluate the cognitive and motivational effects of acute 
and chronic treatments with methylphenidate and whether the effect on one domain 
impacts the effect of the other domain. 
The acute methylphenidate treatment did not affect the number of reference 
memory errors (entries in the non-reinforced arms) and the number of working 
memory errors (re-entries into a reinforced where the sucrose pellet has been 
previously eaten). 
Chronic methylphenidate, early on training (days 1-5)  reduced the number of 
entries in non-reinforced arms and the number of re-entries in the reinforced arms. 
Such effects would be taken as suggestive of spatial reference and working memory 
effects. However, the reduction in the total number of entries and the decrease in the 
travelled distance suggest that these results are more likely a consequence of a 
decrease in locomotor activity - which reduces the number of entries into both the 
reinforced and non-reinforced arms. The decrease in the number of visited arm per 
session may also be caused by a long time to choose in which arm to enter since 
methylphenidate increased the time spent in the central arena. 
Later on training (days 11-20), chronic methylphenidate increased the number 
of re-entries into the reinforced arms. Although this finding could be interpreted as an 
impairment in working memory induced by methylphenidate, this effect was observed 
only for the arms baited with a higher number of pellets. Also, this effect did not 
appear in the group of rats that were trained with the same amount of reward in all 
the arms. Therefore, the increased re-entries to the arms with high rewards are more 
likely a consequence of an effect of methylphenidate on motivation than on spatial 
working memory per se.   
5.1. EFFECTS OF METHYLPHENIDATE ON MEMORY 
Several studies in humans assessed the effects of acute methylphenidate in 
declarative memory (Smith & Farah, 2011) and found a positive effect, although the 
size of this effect varies with the task and dose (Smith & Farah, 2011). The authors 
argue that this difference in the size of the effect may be due to individual differences 
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so that the ideal dose would be different for each person (Smith & Farah, 2011). In 
rodents, the one study of acute effects of methylphenidate showed improvement in 
fear conditioning (Carmack, Howeell, et al., 2014).  While all the mentioned human 
studies and the rodent one tested the effects of methylphenidate on memory 
acquisition or consolidation, we tested the effects of acute methylphenidate in the 
expression of an already established memory. Sloan et al. (Sloan et al.) found similar 
results: intraperitoneal administration of 0.75 and 1.5 mg/kg of methylphenidate did 
not have any effect on the performance on the radial arm maze, in a memory well 
established. Therefore, the human and rodent studies suggest that methylphenidate 
improves memory acquisition and consolidation, but not the expression of well-
established memories. 
Regarding the chronic effects of methylphenidate on memory, previous 
findings are controversial. Sontag et al. (2011) reported that administration of 10, but 
not 2.5 mg/ kg methylphenidate for five days before training impaired learning of a 
spatial reference memory task. On the other hand, Haleem et al. (2015) reported that 
oral 0.25-1 mg/kg methylphenidate administered immediately after each training 
session for one week of training improved memory consolidation, and after a gap of 
one week without any treatment or training, methylphenidate administered during 4 
weeks of retraining improved retention and memory persistence.  
Contrary to the absence of effects reported by Sontag et al. (2011), Veetil and 
Kurian (2011) reported an improvement in memory acquisition and retention in the 
radial arm maze task triggered by 3 mg/kg methylphenidate administered i.p. to rats 
30 minutes every day before training, for four days. One possible explanation for this 
discrepancy is the difference in the task designs used. In the tasks used by Sontag 
and in the current study, animals received methylphenidate before the test, and all 
the behavioural training was carried out with the animals under the effect of the drug. 
In the task used by Veetil and Kurian, animals received the drug before the first trial, 
and the five remaining trials happened with an interval of one hour.  As the half-life of 
the drug in rodents is 1 hour, only one of the six trials was performed under the peak 
concentration of the drug. Thus the increased improvement found by Veetil and 
Kurian occurred mostly during the residual effects of methylphenidate. It is likely that 
molecular events related to memory consolidation were triggered by the first trial and 
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methylphenidate peak concentration coincided with a critical time window of these 
processes, enhancing the outcome. 
The interpretation above is compatible  with the observation made by Haleem 
et al. (2015), which suggest that a small dose of methylphenidate does not have an 
enhancing effect on memory when learning occurs under the effect of the drug; 
however, it may have a beneficial effect when taken after learning, probably 
strengthening memory consolidation. On the other hand, high doses of 
methylphenidate seem to have detrimental effects on memory. 
Which mechanism could explain this apparent enhancement of consolidation? 
The answer is the effects of dopamine in long term potentiation. 
After the acquisition of a new memory, there is a process that strengthens this 
memory known as consolidation (Dudai et al., 2015).   According to a current and 
well-accepted hypothesis, at the cellular level, the mechanism of memory 
consolidation is long-term potentiation (Takeuchi et al., 2014; Dudai et al., 2015). The 
process of long-term potentiation (LTP) was described first by  Bliss and Lomo in 
1973 (Bliss e Lomo, 1973). In their experiment, Bliss and Lomo demonstrate how the 
efficiency of synaptic transmission -the ability of a presynaptic neuron to activate a 
postsynaptic neuron- increased after repetitive electrical stimulation (Bliss e Lomo, 
1973).  
Extensive evidence indicates a role for dopamine in LTP and memory 
consolidation. Dopamine antagonists -particularly D1 receptor antagonists- (Frey et 
al., 1990; O'carroll e Morris, 2004; Saddoris et al., 2015) and dopamine depletion 
(Yang et al., 2002) prevent the formation of LTP. Likewise, the administration of 
Dopamine D1 receptor antagonist, just before learning, impairs memory formation 
(O'carroll et al., 2006; Bethus et al., 2010). Thus, dopamine D1 receptors likely 
mediate the improvement in memory consolidation reported after methylphenidate 
use. Future studies should address the question whether dopamine d1 antagonists 
prevent the beneficial effect of methylphenidate. 
5.2. EFFECTS OF METHYLPHENIDATE ON EXPLORATORY ACTIVITY 
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Animals that received the two higher doses of methylphenidate reduced their 
exploratory activity, and this effect was likely not a consequence of increased anxiety 
or reduced locomotion (we did not observe any of those in the elevated plus maze or 
in the open field, both tasks designed to assess anxiety and locomotion). Two factors 
may be contributing to this decrease in exploratory activity: an effect on motivation for 
eating the sucrose pellets, and an effect on the decision-making time. 
Animals treated with 3 mg/kg of methylphenidate ate fewer pellets when 
exposed to 20 g sucrose pellets for a limited interval of time. This observation 
complies with previous studies (Alam & Najam, 2015; Elfers & Roth, 2011; Thanos et 
al., 2015), which also showed a reduction in food intake after chronic 
methylphenidate treatment. This evidence is compatible with our observation that the 
reduction in exploratory activity only happened during the first five days. Thus, it is 
possible that the reduction in locomotor activity observed in the first five days of 
treatment reflects a reduction in appetite. 
The other factor that may explain the reduction in exploratory activity is an 
effect in decision making: rats treated with the higher doses of methylphenidate might 
take longer to decide which arm to enter. Methylphenidate increased the number of 
trials on which animals spend more than 20 seconds in the central arena of the radial 
maze (this breaking point was selected because the mean + SD of the time the 
control group spent in the central arena was 11 + 9 seconds). In these trials, we 
found a negative correlation between the time spent in the central compartment and 
the number of re-entries in the reinforced arms, only for the animals treated with 3 
mg/kg. Thus, rats treated with 3mg/kg of methylphenidate made a better choice 
(fewer re-entries) but took longer to decide which arm to enter next. The time rats 
spent deciding might reduce the time they spent exploring, which may explain the 
reduced exploratory activity.  
This finding is in agreement with human studies by Franke et al. (2017) that 
tested the effects of methylphenidate on the performance of highly experienced 
chess players. They found that participants under the effect of methylphenidate took 
longer to complete chess moves, but they also made better moves. The authors 
argue that players took a long time to decide their actions, which led to an enhanced 
quality of their game. Moreover, another study in humans assessing the effects of 
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modafinil –a stimulant with a similar clinical profile to methylphenidate- showed that 
participants under the effect of modafinil had a better performance than controls in a 
decision-making task and a spatial planning task, but also had a slowed latency to 
respond(Turner et al., 2003). Thus, both methylphenidate and modafinil seem to 
affect decision-making by increasing accuracy but decreasing speed. These effects 
may be explained by actions in prefrontal cortex areas (Goldstein e Volkow, 2011; 
Moeller et al., 2014) 
Methylphenidate seems to alter decision-making, by increasing the latency to 
make a decision, but enhancing accuracy. We propose this interpretation based on 
the negative correlation between the time in the central platform and the number of 
re-entries in the reinforced arms in the animals treated with 3 mg/kg of 
methylphenidate. Previous studies in humans showed similar results with 
methylphenidate and modafinil: people under the effect of methylphenidate and 
modafinil make more accurate decisions, but take longer to decide (Turner et al., 
2003; Franke et al., 2017). In the most recent of these studies, Franke et al. (2017) 
suggest that this improvement may be attributed to an action of methylphenidate in 
prefrontal cortex. 
 The prefrontal cortex is the region located in the most anterior part of the brain 
and it is linked to cognitive functions such as planning, problem-solving, and 
decision-making –grouped under the umbrella term “executive functions”- (Yuan e 
Raz, 2014). There is extensive evidence showing the involvement of dopaminergic 
modulation in the prefrontal cortex during cognitive tasks (Wass et al., 2013; Puig, 
Antzoulatos, et al., 2014; Puig, Rose, et al., 2014). At the cellular level, dopamine 
increases the signal-to-noise ratio in the prefrontal (Kroener et al., 2009); during a 
cognitive task, this increase in signal-to-noise ratio could mean an enhancement of 
the neuronal activity devoted to the task, and a decrease of the background activity 
(Kroener et al.).  
Thus, Franke et al. (2017) proposed that methylphenidate improved the 
accuracy in decision-making by an increase in dopamine levels in the prefrontal. 
Indeed, previous studied demonstrated that methylphenidate normalized prefrontal 
activity in cocaine users (Goldstein et al., 2010) and optimized prefrontal activity 
during a cognitive task (Moeller et al., 2014). However, Franke et al. (2017) do not 
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provide an explanation for the increase in the latency to make a decision; further 
studies should clarify this question.  
Another issue to consider regarding the potential benefits of methylphenidate 
in decision-making is that the actions of dopamine in cognitive control follow a U 
inverted shape (Cools e D'esposito, 2011; Htun et al., 2014). This means that there is 
an optimum level of dopamine in the prefrontal that would be beneficial for cognitive 
performance, while levels above or below would have detrimental effects. 
Furthermore, some features like the task demands and the baseline performance 
modulate the relationship between dopamine levels and performance. For example, 
a dopaminergic agonist improved working memory in participants with poor baseline 
performance, and the same drug impaired working memory in participants with high 
baseline performance (Kimberg et al., 1997). Thus, even though the results here 
suggest a beneficial effect of methylphenidate in decision-making, this may change 
for each individual depending on the task that they are executing and on their 
baseline performance. 
5.3. EFFECT ON METHYLPHENIDATE IN MOTIVATION TO SEARCH FOR HIGH 
REWARDS 
One possible explanation for the increase in re-entries is that methylphenidate 
increased the motivation to search for high rewards. Methylphenidate increases 
extracellular levels of dopamine in the striatum (Volkow et al., 2002) and higher 
levels of extracellular dopamine in this system are known to increase motivation to 
work for rewards (Cagniard, Balsam, Brunner, & Zhuang, 2006). Hence, the increase 
in the re-entries to high rewarded arms may reflect an increase in motivation to 
search for high rewards, likely mediated by dopamine. 
Animals treated with the highest dose of methylphenidate showed an increase 
in the re-entries to the high rewarded arms. We propose that this is not an effect in 
working memory –which would be the traditional interpretation- because this increase 
in the number of re-entries did not occur in the low reinforced arms, or in a separate 
group of animals that was trained with the same amount of reward. We propose that 
this increase in the re-entries in the high reward arm may reflect that the animals 
treated with methylphenidate had a higher motivation to search for high rewards and 
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that their memory for the locations for high rewards was stronger than for low 
rewards. Both explanations –the higher motivation and the stronger memory for high 
rewards- require dopamine release in the nucleus accumbens (Saddoris et al., 2015) 
These results can also be explained by a model that was recently proposed by 
our group. According to the model, there are neurons in the nucleus accumbens that 
represent all the locations in the environment called place-to-go cells; when a neuron 
that represent a specific location is activated, the animal will approach toward that 
location (Da Cunha et al., 2009). Thus, the dopamine release evoked by the high 
reward would strengthen the long term potentiation in the neuron that represents the 
location for the high reward, and as a consequence this neuron would be more easily 
activated the next time the animal is exploring the maze; the activation of this neuron 
would result in the approach of the animal toward the location of the high reward.  
Experiments currently carried out by our group have made possible to observe 
some neurons in the nucleus accumbens that behave as place-to-go (unpublished 
data). Future studies could assess the effect of methylphenidate administration in 





In summary, our results demonstrate that methylphenidate does not affect only 
cognitive processes such as memory, but also has an effect on other processes such 
as motivation. Effects on both domains may interact and improve or impair 
performance, depending on the task. The results presented in this study, and the 
literature reviewed, reveal that methylphenidate has complex effects in different 
cognitive and behavioral processes. Although methylphenidate has beneficial effects 
for people with ADHD, it is not clear if its use may benefit healthy subjects given the 
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Appendix A. Colour map is representing the exploratory behaviour of the animals from 
the vehicle group in the radial arm maze. Warm colours indicate higher exploration 






Appendix B. Colour map representing the exploratory behaviour of the animals 
treated with 0.3 mg/kg of methylphenidate in the radial arm maze. Warm colours 
indicate higher exploration than cold colours. The image represents the mean from 






Appendix C. Colour map representing the exploratory behaviour of the animals 
treated with 1 mg/kg of methylphenidate in the radial arm maze. Warm colours 
indicate higher exploration than cold colours. The image represents the mean from 






Appendix D. Colour map representing the exploratory behaviour of the animals 
treated with 3 mg/kg of methylphenidate in the radial arm maze. Warm colours 
indicate higher exploration than cold colours. The image represents the mean from 
the entire experiment. 
 
 
 
